132 related articles for article (PubMed ID: 21168236)
21. The impact of computed tomography screening for lung cancer on smoking behaviors: a teachable moment?
Poghosyan H; Kennedy Sheldon L; Cooley ME
Cancer Nurs; 2012; 35(6):446-75. PubMed ID: 22209869
[TBL] [Abstract][Full Text] [Related]
22. CT screening for lung cancer: Importance of emphysema for never smokers and smokers.
Henschke CI; Yip R; Boffetta P; Markowitz S; Miller A; Hanaoka T; Wu N; Zulueta JJ; Yankelevitz DF;
Lung Cancer; 2015 Apr; 88(1):42-7. PubMed ID: 25698134
[TBL] [Abstract][Full Text] [Related]
23. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
[TBL] [Abstract][Full Text] [Related]
24. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
[TBL] [Abstract][Full Text] [Related]
25. Lung cancer detection with digital chest tomosynthesis: baseline results from the observational study SOS.
Terzi A; Bertolaccini L; Viti A; Comello L; Ghirardo D; Priotto R; Grosso M;
J Thorac Oncol; 2013 Jun; 8(6):685-92. PubMed ID: 23612466
[TBL] [Abstract][Full Text] [Related]
26. The impact of a lung cancer computed tomography screening result on smoking abstinence.
van der Aalst CM; van Klaveren RJ; van den Bergh KA; Willemsen MC; de Koning HJ
Eur Respir J; 2011 Jun; 37(6):1466-73. PubMed ID: 21148233
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography screening and lung cancer outcomes.
Bach PB; Jett JR; Pastorino U; Tockman MS; Swensen SJ; Begg CB
JAMA; 2007 Mar; 297(9):953-61. PubMed ID: 17341709
[TBL] [Abstract][Full Text] [Related]
28. Self-selection effects in smokers attending lung cancer screening: a 9.5-year population-based cohort study in Varese, Italy.
Dominioni L; Rotolo N; Poli A; Paolucci M; Sessa F; D'Ambrosio V; Paddeu A; Mantovani W; Imperatori A
J Thorac Oncol; 2010 Apr; 5(4):428-35. PubMed ID: 20142770
[TBL] [Abstract][Full Text] [Related]
29. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
van Iersel CA; de Koning HJ; Draisma G; Mali WP; Scholten ET; Nackaerts K; Prokop M; Habbema JD; Oudkerk M; van Klaveren RJ
Int J Cancer; 2007 Feb; 120(4):868-74. PubMed ID: 17131307
[TBL] [Abstract][Full Text] [Related]
30. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer.
Jacobs PC; Gondrie MJ; van der Graaf Y; de Koning HJ; Isgum I; van Ginneken B; Mali WP
AJR Am J Roentgenol; 2012 Mar; 198(3):505-11. PubMed ID: 22357989
[TBL] [Abstract][Full Text] [Related]
31. Experience with a CT screening program for individuals at high risk for developing lung cancer.
McKee BJ; Hashim JA; French RJ; McKee AB; Hesketh PJ; Lamb CR; Williamson C; Flacke S; Wald C
J Am Coll Radiol; 2015 Feb; 12(2):192-7. PubMed ID: 25176498
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer screening.
Tanoue LT; Tanner NT; Gould MK; Silvestri GA
Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
[TBL] [Abstract][Full Text] [Related]
33. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial.
Mascalchi M; Belli G; Zappa M; Picozzi G; Falchini M; Della Nave R; Allescia G; Masi A; Pegna AL; Villari N; Paci E
AJR Am J Roentgenol; 2006 Aug; 187(2):421-9. PubMed ID: 16861547
[TBL] [Abstract][Full Text] [Related]
34. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project.
New York Early Lung Cancer Action Project Investigators
Radiology; 2007 Apr; 243(1):239-49. PubMed ID: 17392256
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography screening for lung cancer: prospects of surviving competing causes of death.
Henschke CI; Yip R; Yankelevitz DF; Miettinen OS
Clin Lung Cancer; 2006 Mar; 7(5):323-5. PubMed ID: 16640803
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer death rates by smoking status: comparison of the Three-Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USA.
Marugame T; Sobue T; Satoh H; Komatsu S; Nishino Y; Nakatsuka H; Nakayama T; Suzuki T; Takezaki T; Tajima K; Tominaga S
Cancer Sci; 2005 Feb; 96(2):120-6. PubMed ID: 15723657
[TBL] [Abstract][Full Text] [Related]
37. Annual number of lung cancer deaths potentially avertable by screening in the United States.
Ma J; Ward EM; Smith R; Jemal A
Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
[TBL] [Abstract][Full Text] [Related]
38. Modeling the mortality reduction due to computed tomography screening for lung cancer.
Foy M; Yip R; Chen X; Kimmel M; Gorlova OY; Henschke CI
Cancer; 2011 Jun; 117(12):2703-8. PubMed ID: 21656748
[TBL] [Abstract][Full Text] [Related]
39. Screening for lung cancer. Too many uncertainties, even for smokers.
Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
[TBL] [Abstract][Full Text] [Related]
40. Smoking cessation and relapse during a lung cancer screening program.
Anderson CM; Yip R; Henschke CI; Yankelevitz DF; Ostroff JS; Burns DM
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3476-83. PubMed ID: 19959698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
